Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer

MLA

Kaori Hino, et al. “Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer.” JCO Precision Oncology, Aug. 2022. EBSCOhost, https://doi.org/10.1200/po.22.00135.

APA

Kaori Hino, Tomohiro Nishina, Takeshi Kajiwara, Hideaki Bando, Maho Nakamura, Shigenori Kadowaki, Keiko Minashi, Satoshi Yuki, Takashi Ohta, Hiroki Hara, Takuro Mizukami, Toshikazu Moriwaki, Koushiro Ohtsubo, Masato Komoda, Seiichiro Mitani, Fumio Nagashima, Ken Kato, Takanobu Yamada, Hiroko Hasegawa, … Ichinosuke Hyodo. (2022). Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer. JCO Precision Oncology. https://doi.org/10.1200/po.22.00135

Chicago

Kaori Hino, Tomohiro Nishina, Takeshi Kajiwara, Hideaki Bando, Maho Nakamura, Shigenori Kadowaki, Keiko Minashi, et al. 2022. “Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer.” JCO Precision Oncology, August. doi:10.1200/po.22.00135.